Altered Fractionation: Rationale and Justification for Whole and Partial Breast Hypofractionated Radiotherapy

Seminars in Radiation Oncology

Volumn 21, Issue 1, 2011, Pages 55-65

  Théberge, Valérie ^a   Whelan, Tim ^a   Shaitelman, Simona F ^b   Vicini, Frank A ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADJUVANT CHEMOTHERAPY; ALPHA RADIATION; ARTICLE; BALLOON CATHETER; BETA RADIATION; BRACHYTHERAPY; BREAST CANCER; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RESEARCH; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTRAOPERATIVE RADIOTHERAPY; PARTIAL MASTECTOMY; PATHOLOGICAL ANATOMY; PATIENT SELECTION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOISOTOPE THERAPY; SKIN TOXICITY; TREATMENT OUTCOME; TUMOR VOLUME;

BRACHYTHERAPY; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 78649826210     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2010.08.007     Document Type: Article

References (56)

1. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005, 366:2087-2106. Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
2. Ma A.M., Barone J., Wallis A.E., et al. Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients. Am J Surg 2008, 196:500-504.
3. McCarthy E.P., Ngo L.H., Roetzheim R.G., et al. Disparities in breast cancer treatment and survival for women with disabilities. Ann Intern Med 2006, 145:637-645.
4. Suh W.W., Pierce L.J., Vicini F.A., et al. A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2005, 62:790-796.
5. Miles E.F., Lee W.R. Hypofractionation for prostate cancer: A critical review. Semin Radiat Oncol 2008, 18:41-47.
6. Fletcher G.H. Hypofractionation: lessons from complications. Radiother Oncol 1991, 20:10-15.
7. Cosset J.M. Hypofractionnement en radiothérapie: Le retour?. Cancer Radiother 2005, 9:366-373.
8. Hall E.J., Giaccia A.J. Radiobiology for the Radiologist 2006, Lippincott Williams & Wilkins, Philadelphia, PA.
9. Thames H.D., Bentzen S.M., Turesson I., et al. Time-dose factors in radiotherapy: A review of the human data. Radiother Oncol 1990, 19:219-235.
10. Willams M.V., Denekemp J., Fowler J.F. A review of α/β ratios for experimental tumours: Implications for clinical studies of altered fractionation. Int J Radiat Oncol Biol Phys 1985, 11:87-96.
11. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989, 62:679-694.
12. Yarnold J., Ashton A., Bliss J., et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomised trial. Radiother Oncol 2005, 75:9-17.
13. Owen J.R., Ashton A., Bliss J.M., et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial. Lancet 2006, 7:467-471.
14. Whelan T., MacKenzie R., Julian J., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 2002, 94:1143-1150.
15. Whelan T.J., Pignol J.P., Levine M.N., et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010, 362:513-520.
16. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet Oncol 2008, 9:331-341. The START Trialists' Group.
17. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet 2008, 371:1098-1107. The START Trialists' Group.
18. Haviland J.S., Yarnold J.R., Bentzen S.M. Hypofractionated radiotherapy for breast cancer. N Engl J Med 2010, 362:1843.
19. Moody A.M., Mayles W.P., Bliss J.M., et al. The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol 1994, 33:106-112.
20. Olivotto I.A., Weir L.M., Kim-Sing C., et al. Late cosmetic results of short fractionation for breast conservation. Radiother Oncol 1996, 41:7-13.
21. Galecki F., Hicer-Grzenkowicz J., Grudzien-Kowalska M., et al. Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer-A review. Acta Oncol 2006, 45:280-284.
22. Johansson S., Svensson H., Denekamp J. Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys 2000, 48:745-750.
23. Olsen N.K., Pfeiffer P., Johannsen L., et al. Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients. Int J Radiat Oncol Biol Phys 1993, 26:43-49.
24. Yarnold J., Bloomfield D., LeVay J., et al. Prospective randomized trial testing. 5.7 Gy and 6.0-Gy fractions of whole breast radiotherapy in women with early breast cancer (FAST) trial. Clin Oncol 2004, 16:S30.
25. Freedman G.M., Anderson P.R., Goldstein L.J., et al. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. Int J Radiat Oncol Biol Phys 2007, 68:347-353.
26. Sørlie T., Perou C.M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001, 98:10869-10874.
27. Nuyten D.S., Kreike B., Hart A.A., et al. Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res 2006, 8:R62.
28. Nguyen P.L., Taghian A.G., Katz M.S., et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and Her-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 2008, 26:2373-2378.
29. Fisher B., Anderson S., Redmond C.K., et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995, 333:1456-1461.
30. van Dongen J.A., Voogd A.C., Fentiman I.S., et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000, 92:1143-1150.
31. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002, 347:1227-1232.
32. Ohtake T., Abe R., Kimijima I., et al. Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems. Cancer 1995, 76:32-45.
33. Imamura H., Haga S., Shimizu T., et al. Relationship between the morphological and biological characteristics of intraductal components accompanying invasive ductal breast carcinoma and patient age. Breast Cancer Res Treat 1985, 62:177-184.
34. Vicini F.A., Kestin L.L., Goldstein N.S. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: A pathologic analysis. Int J Radiat Oncol Biol Phys 2004, 60:722-730.
35. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-1241.
36. Veronesi U., Marubini E., Mariani L., et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol 2001, 12:997-1003.
37. Liljegren G., Holmberg L., Bergh J., et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol 1999, 17:2326-2333.
38. King T.A., Bolton J.S., Kuske R.R., et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 2000, 180:299-304.
39. Antonucci J.V., Wallace M., Goldstein N.S., et al. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: A matched-pair analysis with 10-year follow-up. Int J Radiat Oncol Biol Phys 2009, 74:447-452.
40. Arthur D.W., Winter K., Kuske R.R., et al. A phase II trial of brachytherapy alone after lumpectomy for select breast cancer: Tumor control and survival outcomes of RTOG 95-17. Int J Radiat Oncol Biol Phys 2008, 72:467-473.
41. Polgár C., Major T., János F., et al. Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. Radiother Oncol 2010, 94:274-279.
42. • breast brachytherapy registry trial in patients treated with accelerated partial breast irradiation (APBI). Int J Radiat Oncol Biol Phys 2010 May 14, [Epub ahead of print].
43. Cuttino L.W., Kesich M., Jenrette J.M., et al. Multi-institutional experience using the Mammosite radiation therapy system in the treatment of early-stage breast cancer: 2-year results. Int J Radiat Oncol Biol Phys 2008, 71:107-114.
44. Benitez P.R., Streeter O., Vicini F., et al. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Am J Surg 2006, 192:427-433.
45. Chen P.Y., Wallace M., Mitchell C., et al. Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2010, 76:991-997.
46. Wernicke A.G., Gidea-Addeo D., Magnolfi C., et al. External beam partial breast irradiation following breast-conserving surgery: preliminary results of cosmetic outcome of NYU 00-23. Int J Radiat Oncol Biol Phys 2006, 66(suppl 3):S32.
47. Vicini F.A., Winter K., Wong J., et al. Initial efficacy results of RTOG, p 0319, in Three Dimensional Conformal Radiation Therapy (3D-CRT) Confined to the Region of the Lumpectomy Cavity for Stage. I/II breast carcinoma. Int J Radiat Oncol Biol Phys 2010, 77:1120-1127.
48. Intra M., Luini A., Gatti G., et al. Surgical technique of intraoperative radiation therapy with electrons (Eliot) in breast cancer: A lesson learned by over 1000 procedures. Surgery 2006, 140:467-471.
49. Holmes D.R., Baum M., Joseph D. The TARGIT trial: Targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update). Am J Surg 2007, 194:507-510.
50. Polgár C., Fodor J., Major T., et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma-5-year results of a randomized trial. Int J Radiat Oncol Biol Phys 2007, 69:694-702.
51. Hepel J.T., Tokita M., MacAusland S.G., et al. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2009, 75:1290-1296.
52. Jagsi R., Ben-David M.A., Moran J.M., et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 2010, 76:71-78.
53. Cytyc: MammoSite: targeted radiation therapy Accessed April 10th, 2010. http://www.mammosite.com/physicians.
54. Smith B.D., Arthur D.W., Buchholz T.A., et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009, 74:987-1001.
55. Vicini F., Arthur D., Wazer D., et al. Limitations of the American Society of Therapeutic Radiology and Oncology consensus panel guidelines on the use of accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2010 May 24, [Epub ahead of print].
56. Shaitelman S.F., Vicini F.A., Beitsch P., et al. Five-year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite Registry Trial. Cancer 2010, 116:4677-4685.